Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Ajou University
Headquarters: Suwon, South Korea
Website: http://www.ajou.ac.kr/en/
Year Founded: 1973
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Nov 11, 2022
Discovery & Translation
S&K’s small molecule TNF inhibitor; plus Actym’s engineered bacteria platform and more
BioCentury’s roundup of translational news
BioCentury | Apr 14, 2022
Product Development
DDR combos on the horizon at AACR22
The first clinical data for a PARP1-selective inhibitor and deeper profiles of ATR-targeting agents suggest combinations will shape the field’s next act
BioCentury | Nov 7, 2018
Emerging Company Profile
ABL bispecifics
Korean biotech ABL is developing bispecifics for cancer and Parkinson's disease
BioCentury | Jun 15, 2017
Tools & Techniques
Breaking the barrier
Companies are finally finding ways to develop cell-penetrating biologics
BioCentury | Jan 4, 2017
Emerging Company Profile
Orum’s forum
How Orum is delivering antibodies into cells
BioCentury | Dec 15, 2016
Product R&D
p53 and Ras: Back from the dead
Why drug developers haven't given up on p53 and Ras
Items per page:
1 - 10 of 10